Overview
Anri Human practices practicing medicine in Pretoria, South Africa.
Their clinical expertise encompasses Miyoshi Myopathy, Cramp-Fasciculation Syndrome, Dysferlinopathy, and Limb-Girdle Muscular Dystrophy.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Anri Human
Is Anri Human a top-rated expert for Miyoshi Myopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Anri Human is classified as an Experienced expert for Miyoshi Myopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Anri Human participate in research or clinical trials?
Yes. Anri Human has published 12 articles and abstracts on conditions like Miyoshi Myopathy. You can view a list of Anri Human's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cramp-Fasciculation SyndromeHuman isExperienced. Learn about Cramp-Fasciculation Syndrome.
- DysferlinopathyHuman isExperienced. Learn about Dysferlinopathy.
- Limb-Girdle Muscular Dystrophy
- Miyoshi MyopathyHuman isExperienced. Learn about Miyoshi Myopathy.